#006 Inside Novo Nordisk’s Path to Open Source for the Pharma and Beyond Podcast Por arte de portada

#006 Inside Novo Nordisk’s Path to Open Source for the Pharma and Beyond

#006 Inside Novo Nordisk’s Path to Open Source for the Pharma and Beyond

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 Ari Siggaard Knoph from Novo Nordisk shares how the company transitioned from SAS to R for FDA submissions. From early Shiny apps to full-scale open-source workflows, learn how this shift accelerated innovation, attracted top talent, and redefined clinical programming.

In this episode, you will learn:
  • How Novo Nordisk transitioned from legacy systems to R for regulatory submissions
  • How Shiny applications became the catalyst for internal buy-in
  • How open-source adoption has broadened the company’s talent pool and improved productivity
  • Future directions in pharma tech
__________________________________________
More about Appsilon:
► https://www.appsilon.com/
Appsilon empowers pharmaceutical and life sciences companies to leverage open-source technology for faster, data-driven decision-making in regulated environments.
Schedule a free consultation with our expert
► https://www.appsilon.com/contact-us
__________________________________________
or more insights about how technology helps scientists push the boundaries of data analysis and reporting check out our blog:
► http://appsilon.com/blog
LinkedIn: https://www.linkedin.com/company/appsilon/
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones